1. Opening remarks

2. Overview of the pharmacovigilance system in Korea

3. Overview of pharmacovigilance system in Korea Q&A

4. Sharing action plans for the regulatory harmonization in pharmacovigilance

5. Sharing action plans for the regulatory harmonization in pharmacovigilance Q&A

6. Pharmacovigilance and medication error reporting system

7. Pharmacovigilance and medication error reporting system Q&A

8. Sharing various economies’ strategies to improve their pharmacovigilance system (Chile)

9. Sharing various economies’ strategies to improve their pharmacovigilance system (Indonesia)

10. Sharing various economies’ strategies to improve their pharmacovigilance system (Philippines)

11. Sharing various economies’ strategies to improve their pharmacovigilance system (Taiwan)

12. Sharing various economies’ strategies to improve their pharmacovigilance system (Thailand)

13. Effective risk communication - PMDA experience

14. Effective risk communication - PMDA experience Q&A

15. Quality management of pharmacovigilance - Pharmacovigilance inspection

16. Quality management of pharmacovigilance - Pharmacovigilance inspection Q&A

17. Principles of adverse event assessment - Signal detection

18. Principles of adverse event assessment - Q&A

19. Tools for enhanced pharmacovigilance_ advanced signal detection

20. Tools for enhanced pharmacovigilance_ advanced signal detection Q&A

21. Risk management plan (RMP) - Specific product-related RMP, tools and activities

22. Risk management plan (RMP) - Specific product-related RMP, tools and activities Q&A

23. Wrap up and Closing Remarks